Günther Loidl
Chief Tech/Sci/R&D Officer presso BACHEM HOLDING AG
Patrimonio netto: 1 M $ in data 31/03/2024
Profilo
Il Dr. Gnther Loidl è Chief Technology Officer di Bachem Holding AG. Fa parte del Consiglio di Amministrazione di Bachem AG. Ha conseguito il suo dottorato presso il Max Planck Institute of Biochemistry.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
| 31/12/2022 | 14 995 ( 0.02% ) | 1 M $ | 31/03/2024 |
Posizioni attive di Günther Loidl
| Società | Posizione | Inizio |
|---|---|---|
| BACHEM HOLDING AG | Chief Tech/Sci/R&D Officer | 01/01/2015 |
Bachem AG
 Bachem AG Pharmaceuticals: MajorHealth Technology Bachem AG engages in the sale and distribution of active pharmaceutical ingredients and research grade products. The firm’s products include peptides and complex organic molecules, as well as new chemical entities and generic active pharmaceutical ingredients. It also focuses on peptide research and development, including custom peptide synthesis. The company was founded by Peter Grogg in 1971 and is headquartered in Bubendorf, Switzerland. | Director/Board Member | 01/01/2000 |
Formazione di Günther Loidl
| Max Planck Institute of Biochemistry | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| BACHEM HOLDING AG | Health Technology |
| Aziende private | 1 |
|---|---|
Bachem AG
Bachem AG Pharmaceuticals: MajorHealth Technology Bachem AG engages in the sale and distribution of active pharmaceutical ingredients and research grade products. The firm’s products include peptides and complex organic molecules, as well as new chemical entities and generic active pharmaceutical ingredients. It also focuses on peptide research and development, including custom peptide synthesis. The company was founded by Peter Grogg in 1971 and is headquartered in Bubendorf, Switzerland. | Health Technology |
- Borsa valori
- Insiders
- Günther Loidl
